• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Tuesday, July 8, 2025
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

Most expensive drug ever approved by FDA, a $3.5 million-per-dose gene therapy for hemophilia B

by Sumbul Farid
November 24, 2022
in Business, Markets, Tech, Trending, World
Reading Time: 2 mins read
0
3D Technology Ventures Into The Field OF Pharmaceuticals; World’s First 3D Printed Drug Hits The Market Today
TwitterWhatsappLinkedin

On Tuesday, U.S. health regulators cleared the first gene therapy for hemophilia. A one-time treatment costs $3.5 million for the blood-clotting disorder. The Food and Drug Administration (FDA) gave approval to Hemgenix, an IV treatment for adults with hemophilia B- the less common form of the genetic disorder which mostly affects men.

You might also like

Linkrunner Raises ₹5 Cr to Revolutionize App Attribution in India’s Booming Mobile Market

BigBasket Strengthens Leadership Bench with Deepika Khattar Bhan’s Appointment

Adobe Photoshop Announces New AI Features for Web App Users


Right now, patients receive regularly, expensive IVs of a protein that facilitate the clotting of blood and stop bleeding.
The Pennsylvania based drugmaker CSL Behring, announced the $3.5 million price tag shortly after getting a green nod from FDA, saying its drug would ultimately decrease health care costs because patients would have fewer bleeding incidents and need fewer clotting treatments.

As per a study cited by the National Library of Medicine, the cost makes Hemgenix the most expensive medicine in the world, easily surpassing Novartis’ Zolgensma gene therapy for spinal muscular atrophy (SMA), which estimates about $2 million per dose and is also a single-dose medicine.

Mostly in the U.S., most of the cost of the new treatment is paid by the insurers, not patients. This covers private plans and government programs.

After years of research, gene therapies have begun reshaping cancer treatment and rare inheritable diseases with medicines that can improve or correct mutations implanted in people’s genetic code. Hemgenix is the first one of it’s kind treatment for hemophilia and several other drug making companies are researching on gene therapies for the more common form of the disorder, hemophilia A.

 FDA’s Dr. Peter Marks said,
“Today’s approval provides a new treatment option for patients with hemophilia B and represents important progress in the development of innovative therapies.”

However, the agency did not particularly mention how long the treatment works. But said that patients should benefit in terms of reduced bleeding and increased clotting for years.

The disease mostly strikes males and is caused due to mutations in the gene for a protein needed for blood clotting. Minor cuts or bruises can be life-threatening, and many people need treatments once or more a week to prevent fatal bleeding. If left untreated, hemophilia can cause bleeding that seeps into joints and internal organs, including the brain.

Hemgenix delivers a working gene for the clotting protein to the liver, where it is made.

Hemophilia B affects about 1 in 40,000 people and accounts for roughly 15% of those with the disease, according to the FDA.
The American regulatory authority FDA said it granted approval on the basis of two small studies, including one that showed those taking the drug had increased levels of the clotting protein, decreased need for standard treatment and a 54% decrease in bleeding problems.

Earlier this year, European regulators approved a similar gene therapy for hemophilia A. That drug, from drugmaker BioMarin, is still under review at the FDA.

Tags: drugFDAhaemophiliaUSA
Tweet54SendShare15
Previous Post

Black Friday Deals – Microsoft Xbox Series X for $399

Next Post

Amazon to invest $1 billion annually to produce movies for theaters

Sumbul Farid

Recommended For You

Linkrunner Raises ₹5 Cr to Revolutionize App Attribution in India’s Booming Mobile Market

by Ishaan Negi
July 8, 2025
0
Linkrunner Raises ₹5 Cr to Revolutionize App Attribution in India’s Booming Mobile Market

In a significant milestone for India’s growing app economy, Linkrunner, the country’s first AI-powered mobile measurement partner (MMP), has raised ₹5 crore in a pre-seed funding round. The...

Read more

BigBasket Strengthens Leadership Bench with Deepika Khattar Bhan’s Appointment

by Ishaan Negi
July 8, 2025
0
Tata owned Bigbasket’s revenue goes over ₹10,000 Cr, loss reduces to ₹1,415

In a strategic leadership reshuffle aimed at sharpening its edge in the fiercely competitive quick commerce market, Tata-backed BigBasket is set to welcome Deepika Khattar Bhan to its...

Read more

Adobe Photoshop Announces New AI Features for Web App Users

by Techstory
July 8, 2025
0
Adobe Photoshop Announces New AI Features for Web App Users

The web version of Photoshop just levelled up (big time). What’s really got people excited is no downloads. No clunky setup. Just open your browser and boom –...

Read more
Next Post
Amazon reportedly announced its yearly hardware event on 28th of September

Amazon to invest $1 billion annually to produce movies for theaters

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?